Journal article · 2010
Development of drug for Alzheimer′s disease
Zhongguo yaoke daxue xuebao · Published 1 January 2010
In brief
“Development of drug for Alzheimer′s disease” is a 2010 journal article by Hong Liao, published in Zhongguo yaoke daxue xuebao. OpenAlex counts 0 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 1
Abstract
Alzheime′s disease(AD) is a heterogeneous neurodegenerative disease,which is characterized by severe memory deficits and cognitive impairment.Current FDA-approved drugs for AD aim at the correction of neurotransmitter abnormalities.They produce limited symptomatic effects but do not slow disease progression.During recent years,with the further understanding of the mechanisms that initiate and perpetuate AD,great progress has been made in… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Liao, H. (2010). Development of drug for Alzheimer′s disease. Zhongguo yaoke daxue xuebao. https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYD201005001.htm
MLA 9
Liao, Hong. “Development of drug for Alzheimer′s disease.” Zhongguo yaoke daxue xuebao, 2010. https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYD201005001.htm.
Chicago
Liao, Hong. 2010. “Development of drug for Alzheimer′s disease.” Zhongguo yaoke daxue xuebao. https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYD201005001.htm.
Harvard
Liao, H. (2010) ‘Development of drug for Alzheimer′s disease’, Zhongguo yaoke daxue xuebao. Available at: https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYD201005001.htm.
IEEE
H. Liao, “Development of drug for Alzheimer′s disease,” Zhongguo yaoke daxue xuebao, 2010.
BibTeX
@article{liao2010development,
title = {{Development of drug for Alzheimer′s disease}},
author = {Liao, Hong},
journal = {Zhongguo yaoke daxue xuebao},
year = {2010},
url = {https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYD201005001.htm}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- drug development
- amyloid-beta
- tau protein
- neuroprotective agents
- disease-modifying therapy
- memory impairment
- cognitive impairment
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Liao, H. (2010). Development of drug for Alzheimer′s disease. Zhongguo yaoke daxue xuebao. https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYD201005001.htm
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Hong Liao.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.